GRI Bio Inc (GRI)
0.428
+0.03
(+6.81%)
USD |
NASDAQ |
May 16, 16:00
0.428
0.00 (0.00%)
After-Hours: 20:00
GRI Bio Total Liabilities (Quarterly): 1.789M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.789M |
| December 31, 2023 | 2.697M |
| September 30, 2023 | 2.177M |
| Date | Value |
|---|---|
| June 30, 2023 | 1.604M |
| March 31, 2023 | 2.066M |
| December 31, 2022 | 2.008M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.604M
Minimum
Jun 2023
2.697M
Maximum
Dec 2023
2.057M
Average
2.037M
Median
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 16.06M |
| AIM ImmunoTech Inc | 9.147M |
| IGC Pharma Inc | 2.206M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Protalix BioTherapeutics Inc | 60.04M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.587M |
| Shareholders Equity (Quarterly) | 2.798M |